產(chǎn)品名稱 | 乳腺癌易感基因2相關(guān)蛋白抗體 |
英文名稱 | Anti-BRAF35 |
規(guī)格 | 0.2ml/200μg |
濃度 | 1mg/1ml |
價(jià)格 | 來(lái)電可享受優(yōu)惠 |
英文名稱 Anti-BRAF35
中文名稱 乳腺癌易感基因2相關(guān)蛋白抗體
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來(lái)源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Cow
產(chǎn)品類型 一抗
研究領(lǐng)域 腫瘤 細(xì)胞生物 轉(zhuǎn)錄調(diào)節(jié)因子
蛋白分子量 predicted molecular weight: 36kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from humanBRAF35
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 Preservative: 15mM Sodium Azide, Constituents: 1%BSA, 0.01M PBS, pH 7.4
產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by theend user.
保存條件 Store at -53 °C for oneyear.
別 名 BRAF25; BRAF35; BRCA 2 Associated Factor (35kDa);BRCA2 associated factor 35; BRCA2-associated factor 35; High Mobility GroupProtein 20B; HM20B_HUMAN; HMG 20B; HMG box containing protein 20B; HMGbox-containing protein 20B; HMG domain-containing protein 2; HMGdomain-containing protein HMGX2; hmg20b; HMGX2; PP7706; pp8857; SMARCE1 relatedprotein; SMARCE1-related protein; SMARCE1r; sox like; Sox like transcriptionalfactor; Sox-like transcriptional factor; SOXL; Structural DNA binding proteinBRAF35; Structural DNA-binding protein BRAF35; SWI/SNF related; SWI/SNF relatedmatrix associated actin dependent regulator of chromatin subfamily E member 1related; SWI/SNF-related matrix-associated actin-dependent regulator ofchromatin subfamily E member 1-related.
